Monday, April 27, 2009

NGC Update Service: April 27, 2009

National Quality Measures Clearinghouse - New This Week Banner for the National Guideline Clearinghouse

What's New This Week

April 27, 2009

Centers for Disease Control and Prevention

Recommended immunization schedules for persons aged 0 through 18 years: United States, 2009. This updates a previously published guideline summary.


National Collaborating Centre for Mental Health

Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. This updates a previously published guideline summary.

Drug misuse: opioid detoxification.


National Institute for Health and Clinical Excellence (NICE)

Acutely ill patients in hospital: recognition of and response to acute illness in adults in hospital.


Program in Evidence-based Care

Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations.

The management of thymoma: guideline recommendations.


Society of Obstetricians and Gynaecologists of Canada

Diagnosis and classification. In: Diagnosis, evaluation and management of the hypertensive disorders of pregnancy.

Prediction, prevention, and prognosis of preeclampsia. In: Diagnosis, evaluation and management of the hypertensive disorders of pregnancy.

Treatment of the hypertensive disorders of pregnancy. In: Diagnosis, evaluation and management of the hypertensive disorders of pregnancy.


University of Michigan Health System

Functional constipation and soiling in children. This updates a previously published guideline summary.


Wisconsin Diabetes Prevention and Control Program

Wisconsin essential diabetes mellitus care guidelines. This updates a previously published guideline summary.



Newly Submitted


To view a list of other guidelines in the NGC work queue, please visit our Guidelines In Progress page.

Health Awareness Topics - April 2009


How to Participate

  • Submit guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
  • Suggest a guideline for possible inclusion: Submit your suggestions for evidence-based guidelines that you would like to see included in NGC.
  • Suggest a Guideline Synthesis topic: We welcome your suggestions for guideline synthesis topics!

Conference News

On June 4-5, 2009, the US Cochrane Center Presents a "Stakeholder Summit on Using Quality Systematic Reviews to Inform Evidence-based Guidelines," in Baltimore, Maryland. Join leading evidence-based clinical guideline developers, and hear from experts on the latest methods and practices for systematic review and guideline development. Share successes, pitfalls, current challenges, and future opportunities for evidence-based guidelines. For more information see the US Cochrane Center Conferences and Event page.

Hospital-Acquired Conditions

CMS has expanded its list of hospital-acquired conditions in its final rule. According to CMS, use of evidence-based guidelines may help prevent hospital-acquired conditions. The new rule is available in the Federal Register. For more information see NGC's listing of current guidelines on hospital-acquired conditions.

Healthy People 2010

See NGC's Frequently Requested Search page for a selection of pre-set searches of NGC for guidelines related to the Healthy People 2010 focus areas, as well as other public health and patient safety topics.

Recent U.S. Food and Drug Administration (FDA) Advisory

  • April 14, 2009: Ceftriaxone (marketed as Rocephin and generics): FDA notified healthcare professionals of an update to a previous alert that addresses the interaction of ceftriaxone with calcium-containing products. FDA now recommends that ceftriaxone and calcium-containing products may be used concomitantly in patients >28 days of age.
  • April 8, 2009: Raptiva (efalizumab): Withdrawn from U.S. market: Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of psoriasis, from the U.S. market due to a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML). By June 8, 2009, Raptiva will no longer be available in the United States.

NGC's Sister Resources

Find Innovations and QualityTools classified by disease or clinical category, patient population, stage of care, setting of care, and more in AHRQ's Health Care Innovations Exchange Web site.

Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).

Other Resources

To locate a previous issue of "What's New This Week," go to the What's New Archive.

Questions or suggestions about the "What's New" feature are welcome -- please send e-mail to: info@guideline.gov.

Submit your guidelines for inclusion in the National Guideline Clearinghouse!


Search Help
Detailed Search

To sign up for our weekly NGC Update Service or to manage your subscriptions, visit the Subscription Management page.

You may also be interested in subscribing to AHRQ's Electronic Newsletter. Issued periodically as news warrants, AHRQ's Electronic Newsletter describes the results of AHRQ-funded studies, announces new print and electronic resources, updates the status of current funding opportunities, and much more. To subscribe to this free service, please go to the AHRQ Web site.

No comments:

Post a Comment